Exhibit 99.1

                    BILL OF SALE, ASSIGNMENT, ACCEPTANCE
                         AND ASSUMPTION AGREEMENT

This BILL OF SALE, ASSIGNMENT, ACCEPTANCE AND ASSUMPTION AGREEMENT, made,
executed and entered into as of December 29, 2006, by and among Technology
Funding Venture Partners IV Liquidating Trust (the "Assignor" or the "Trust")
and Technology Funding Ltd., (the "Assignee") or its nominees, including but
not limited to Technology Funding Group, LLC and/or Dakota Equities, LLC.

                             R E C I T A L S

WHEREAS, the Liquidating Trust Agreement requires the Trustee, in its sole
discretion, to liquidate the assets of the Trust as promptly as possible
consistent with obtaining fair value for such assets; and

WHEREAS, the Trustee is hereby authorized to cause the Trust to sell or
distribute assets to the Trustee or associated entity but only in accordance
with Section 3.6 of the Liquidating Trust Agreement; and

WHEREAS, pursuant to Section 3.6, the Trustee accepted a bona fide third-party
bid on October 26, 2006, from Industry Ventures Acquisition Fund II (Aperture),
L.P. ("IVAF") and Industry Ventures Fund IV, L.P. ("IVF") for the acquisition
and transfer of most of the Trust's remaining portfolio securities, excluding
holdings in the following companies and venture capital limited partnerships:
   Dakota Arms, Inc.
   Dakota Holdings, LLC
   Triangle Biomedical Sciences, Inc.
   El Dorado Ventures III, L.P.
   Medical Science Partners, L.P.
   Onset Enterprises Associates, L.P.; and

WHEREAS, pursuant to Section 3.6, in the event that no bona fide offers are
received after sixty (60) days of a thorough and diligent marketing effort
commencing with the decision to liquidate the Partnership's assets, the
Trustee or an associated entity may purchase the assets at a price no less
than the current Fair Value; and

WHEREAS, an independent third-party investment bank, Burnham Securities Inc.,
did conduct such a thorough and diligent marketing effort and has been unable
to identify any buyers for the remaining assets.

WHEREAS, pursuant to Section 3.6, the Managing General Partners have
periodically updated and revised the Fair Value of each holding in order to
reflect new events, changing market conditions, more experience with investee
companies or additional information, any of which may require the revision of
previous estimate, and the Fair Values of the assets listed above at March 31,
2006, June 30, 2006, and December 29, 2006, is attached hereto as Exhibit A.

NOW, THEREFORE, in consideration of the foregoing premises and for the
following purchase prices:
   Dakota Arms, Inc. - $100
   Dakota Holdings, LLC - $100
   Triangle Biomedical Sciences, Inc. - $1
   El Dorado Ventures III, L.P. - $10
   Medical Science Partners, L.P. - $10
   Onset Enterprises Associates, L.P. - $10
and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged:

ASSIGNMENT.  The Assignor does hereby convey, assign, transfer, sell and
deliver unto the Assignee and its successors and assigns, forever, all of the
Assignor's right, title and interest in, to and under all of the assets of the
Assignor, including without limitation any accounts receivable, limited
partnership interest, beneficial interest, rights in litigation, security
interests, contract rights or agreements, rights to payment or distributions
or similar rights that the Assignor may possess in same (together, the
"Transferred Assets").

ACCEPTANCE AND ASSUMPTION.  The Assignee accepts the foregoing conveyance,
assignment, transfer and delivery of the Transferred Assets and agrees to
assume all liabilities and obligations relating to the Transferred Assets
(the "Assumed Obligations").

TO HAVE AND TO HOLD the Transferred Assets and the Assumed Obligations unto
the Assignee, its successors and assigns, FOREVER.

The Assignor hereby constitutes and appoints the Assignee and its successors
and assigns as its true and lawful attorneys-in-fact in connection with the
transactions contemplated by this instrument, with full power of substitution,
in the name and stead of the Assignor but on behalf of and for the benefit of
the Assignee and its successors and assigns, to demand and receive any and all
of the assets, properties, rights and business hereby conveyed, assigned, and
transferred or intended so to be, and to give receipt and releases for and in
respect of the same and any part thereof, and from time to time to institute
and prosecute, in the name of the Assignor or otherwise, for the benefit of the
Assignee or its successors and assigns, proceedings at law, in equity, or
otherwise, which the Assignee or its successors or assigns reasonably deem
proper in order to collect or reduce to possession or endorse any portion of
the Transferred Assets and to do all acts and things in relation to the assets
which the Assignee or its successors or assigns reasonably deem desirable.

The instrument shall be binding upon and shall inure to the benefit of the
respective successors and assigns of the Assignor and the Assignee.

This instrument shall be construed and enforced in accordance with the laws of
the State of Delaware, without regard to conflict of law.

IN WITNESS WHEREOF, the undersigned have executed this Bill of Sale,
Assignment, Acceptance and Assumption Agreement under seal on the date first
above written.


                                    ASSIGNOR

                                    Technology Funding Venture Partners IV
                                    Liquidating Trust
                                    By: Technology Funding, Inc. as Trustee

                                    By: /s/ Charles R. Kokesh, President


                                    ASSIGNEE

                                    Technology Funding Ltd.,

                                    By: /s/ Charles R. Kokesh, General Partner